Background An estimated 150 million people worldwide are infected with hepatitis C virus (HCV).
HIV co-infection accelerates the progression of HCV and represents a major public …

The need to improve access to care and treatment for chronic hepatitis C virus (HCV) infection
in resource-limited settings is receiving increasing attention. Key priorities for scaling up …

Although infections caused by methicillin-resistant Staphylococcus aureus with reduced
vancomycin susceptibility (SA-RVS) have been reported from a number of countries, including …

Recent outbreaks of Ebola virus disease (2013–2016) and Zika virus (2015–2016) bring
renewed recognition of the need to understand social pathways of disease transmission and …

We assessed the effectiveness and safety of standardised, shorter multidrug-resistant
tuberculosis (MDR-TB) regimens by pooling data from observational studies. Published studies …

We sought to compare the effectiveness of two World Health Organization (WHO)-recommended
regimens for the treatment of rifampin- or multidrug-resistant (RR/MDR) tuberculosis (TB…

Ambulatory, community-based care for multi-drug resistant tuberculosis (MDR-TB) has been
found to be effective in multiple settings with high cure rates. However, little is known about …

Fewer than 20% of patients with multidrug-resistant (MDR) tuberculosis are receiving
treatment and there is an urgent need to scale up treatment programmes. One of the biggest …

We describe 27 children and adolescents< 18 years of age who received bedaquiline during
treatment for multidrug-resistant tuberculosis. We report good treatment responses and no …

…Philipp du Cros…Philipp du Cros… This finding contrasts with an analysis of patients in
thePhilippines, who were at increased risk of default with increasing numbers of drugs in their …